Table 5 of
Dionne, Mol Vis 2016; 22:177-188. Table 5 of
Dionne, Mol Vis 2016; 22:177-188.
Table 5. Percentage of subjects in each group with analyte* expression levels above the LOD for both methods.
| Analytes | CL | DE | NOR | |||
|---|---|---|---|---|---|---|
| Luminex | Microarray | Luminex | Microarray | Luminex | Microarray | |
| IL-1b | 30% | 5% | 15% | 15% | 20% | 5% |
| IL-2 | 0% | 20% | 0% | 35% | 0% | 50% |
| IL-4 | 30% | 30% | 20% | 5% | 15% | 10% |
| IL-5 | 0% | 0% | 0% | 5% | 0% | 0% |
| IL-6 | 55% | 10% | 80% | 25% | 45% | 35% |
| IL-7 | 100% | 0% | 90% | 25% | 100% | 20% |
| IL-8 | 100% | 20% | 100% | 25% | 100% | 25% |
| IL-10 | 0% | 0% | 0% | 0% | 5% | 0% |
| IL-12(p70) | 0% | 5% | 0% | 15% | 0% | 20% |
| IL-13 | 20% | 10% | 15% | 25% | 20% | 35% |
| IFNy | 0% | 0% | 0% | 20% | 0% | 10% |
| GM-CSF | 0% | 40% | 0% | 5% | 0% | 0% |
| TNFα | 0% | 15% | 5% | 0% | 0% | 0% |